Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Renata Pasqualini
University of New Mexico Health Scis Ctr, Department: Internal Medicine/medicine
Should you be removed from our database? Contact us at [email protected]. Read more below.
Arrowhead Pharmaceuticals
Intellectual property rights (e.g., royalties, patents, copyrights) not from the awardee Institution
Dr. Pasqualini is a developer of intellectual property licensed to Arrowhead Pharmaceuticals. This intellectual property will be used to develop new probes for imaging applications on this study
Targeting Lymphatic Vessels for Ligand Directed Imaging
NARRATIVE There are very few molecular markers associated with disease progression involving the lymphatic endothelium described in the literature. To address the serious deficiency in this important field, we recovered small peptides that bind to human afferent lymphatic vessels surgically resected from melanoma patients. Our proposed studies will enable the development of ligand-directed imaging agents to study the lymphatic system.
Filed on August 10, 2017.
Tell us what you know about Renata Pasqualini's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Renata Pasqualini”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Renata Pasqualini | Rice University | Conflict of Interest | Arrowhead Pharmaceuticals | $20,000 - $39,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.